LRCX
New money, same chip cycle drama
Lam Research just got a bigger thumbs-up from Merit Financial Group LLC, which upped its stake by 65.4% and now holds about 66,421 shares worth roughly $11.37 million. In market-land, that’s basically the institutional equivalent of saying, “Yeah, we’d like a bigger slice of that semiconductor pie.”
Why you should care
This isn’t some random portfolio tweak in a vacuum. Lam also just posted a strong quarter: EPS of $1.27 beat the Street’s $1.17 estimate, revenue came in at $5.34 billion, and sales jumped 22.1% from a year ago. Then management leaned into the optimism with Q3 2026 guidance of $1.25 to $1.45 in EPS.
The rest of the tape is still busy
The article also notes that Wall Street is still leaning bullish on LRCX, with a consensus rating of "Moderate Buy" and price targets stretching into the $290s and $300s. Lam even tossed in a quarterly dividend, because apparently the company wanted to remind everyone it can grow and pay you a little something for waiting.
Big picture
For investors, the takeaway is simple: Lam Research is still getting attention from both institutions and analysts, and the latest earnings print didn’t exactly scare anyone away. When the chip equipment cycle is choppy, that kind of steady confidence can matter a lot.